Coppell Advisory Solutions’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-194	Closed	-$1.46K	–	475
2024 Q4	$1.46K	Sell	194 -2,556	-93%	-$19.2K	﹤0.01%	1596
2024 Q3	$21K	Buy	+2,750	New	+$21K	﹤0.01%	859